Addiction Treatment Modalities & Therapeutic Approaches Flashcards
7 cards from real ADM practice questions. Tap to flip, then mark Knew It or Still Learning — missed cards come back until you master them.
Read the first 7 Addiction Treatment Modalities & Therapeutic Approaches flashcards as text
Which methadone treatment characteristic makes it uniquely appropriate for patients with opioid use disorder who have poor social stability or prior failed office-based treatment?
Answer: It requires daily observed dosing at an opioid treatment program, providing daily structure and monitoring
Methadone for OUD is dispensed through federally regulated opioid treatment programs (OTPs), where daily observed dosing provides structure, monitoring, and access to wraparound services.
A clinician using the Stages of Change model (Prochaska & DiClemente) identifies a patient who acknowledges a substance problem and is seriously thinking about quitting within the next 6 months but has not yet made plans. Which stage does this represent?
Answer: Contemplation
The Contemplation stage is characterized by ambivalence — the patient recognizes the problem and is considering change within 6 months but has not committed to a specific action plan.
Network Therapy for addiction treatment is distinguished by its use of which unique element not found in standard individual therapy?
Answer: Involving the patient's social network (family/friends) in therapy sessions to support recovery
Network Therapy actively recruits family members and close friends to participate in sessions as a recovery support network, directly leveraging the patient's social environment.
Which of the following best describes the mechanism of action of disulfiram (Antabuse) in treating alcohol use disorder?
Answer: Inhibits aldehyde dehydrogenase, causing acetaldehyde accumulation and an aversive reaction if alcohol is consumed
Disulfiram inhibits aldehyde dehydrogenase, causing toxic acetaldehyde to accumulate when alcohol is consumed, producing flushing, nausea, palpitations, and hypotension as an aversive deterrent.
Low-barrier buprenorphine prescribing (e.g., initiating treatment in emergency departments or without urine drug screening requirements) is supported by evidence showing which outcome?
Answer: Significantly improved treatment engagement and retention in patients who would not otherwise access traditional treatment
Studies such as the Yale ED-initiated buprenorphine trial demonstrate that low-barrier prescribing substantially increases linkage to care and treatment retention among high-risk, underserved populations.
Seeking Safety is a manualized treatment designed to address which specific co-occurring condition alongside substance use disorder?
Answer: PTSD and trauma
Seeking Safety was developed specifically to treat co-occurring PTSD and substance use disorder, teaching coping skills without requiring trauma processing as a prerequisite.
For patients undergoing opioid detoxification, alpha-2 adrenergic agonists such as clonidine or lofexidine are used primarily to manage which withdrawal symptoms?
Answer: Autonomic symptoms including sweating, tachycardia, hypertension, and anxiety
Alpha-2 agonists suppress noradrenergic hyperactivity during opioid withdrawal, effectively reducing autonomic symptoms such as diaphoresis, tachycardia, hypertension, and anxiety.